keyword
https://read.qxmd.com/read/38655996/management-of-sialorrhea-in-children-a-systematic-review
#1
JOURNAL ARTICLE
Manuela Leitão de Vasconcelos, Divany Guedes Pereira da Cunha, Giorvan Ânderson Dos Santos Alves, Tatiana Carneiro da Cunha Almeida Santos, Luiz Medeiros de Araujo Lima-Filho, Karinna Veríssimo Meira Taveira, Cristiano Miranda de Araújo, Leandro Pernambuco
No abstract text is available yet for this article.
2024: Revista da Associação Médica Brasileira
https://read.qxmd.com/read/38645944/magnetic-resonance-imaging-in-rabies-encephalitis-a-case-report-and-review-of-the-literature
#2
Abasin Tajmalzai, Ataullah Zarabi
Rabies is an acute fatal disease of the central nervous system. Neuroimaging plays an important role, especially in establishing an early diagnosis and distinguishing it from other types of encephalitis. This case report aims to give a brief review of this condition and report the less common MRI findings of the disease. We herein report a case of a 61-year-old male bitten by a stray dog who presented with fever, vomiting, headache, sialorrhea, dysarthria, dysphagia, and upper limb weakness which progressed to lower limbs on the next day...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38634369/polymorphisms-in-erbb4-and-tacr1-associated-with-dry-mouth-in-clozapine-treated-patients
#3
JOURNAL ARTICLE
Hanna Puolakka, Anssi Solismaa, Leo-Pekka Lyytikäinen, Merja Viikki, Niko Seppälä, Nina Mononen, Terho Lehtimäki, Olli Kampman
OBJECTIVE: Sialorrhea is a common and uncomfortable adverse effect of clozapine, and its severity varies between patients. The aim of the study was to select broadly genes related to the regulation of salivation and study associations between sialorrhea and dry mouth and polymorphisms in the selected genes. METHODS: The study population consists of 237 clozapine-treated patients, of which 172 were genotyped. Associations between sialorrhea and dry mouth with age, sex, BMI, smoking, clozapine dose, clozapine and norclozapine serum levels, and other comedication were studied...
April 18, 2024: Acta Neuropsychiatrica
https://read.qxmd.com/read/38633105/profile-of-patients-with-maxillofacial-space-infections-and-associated-risk-factors
#4
JOURNAL ARTICLE
Srikanth Gadicherla, Kirti Manglani, Kalyana C Pentapati, Adarsh Kudva, Chithra Aramanadka, Rajaji Chandravel
OBJECTIVE: To evaluate the profile of patients operated for maxillofacial space infections and associated risk factors for the length of hospital stay. MATERIALS AND METHODS: We conducted a retrospective study among patients operated for maxillofacial infections at our center from 2010 to 2020. Information collected from the records were age, sex, type and number of spaces involved, clinical signs and symptoms (pain, swelling, toothache, sore throat, otalgia, hoarseness, headache, cough, neck swelling, rancid breath, sialorrhea, gingival swelling, muffled voice, trismus, fever, dysphagia, odynophagia, malaise, lymphadenopathy, dyspnoea, pus discharge), treatment modality, total leukocyte count, evidence of bacterial growth, comorbidities, complications if any and length of hospital stay...
2024: TheScientificWorldJournal
https://read.qxmd.com/read/38608010/clozapine-treatment-for-aggressive-behaviors-in-youths-with-neurodevelopmental-disorders
#5
JOURNAL ARTICLE
Stefano Berloffa, Gabriele Masi, Francesca Falcone, Valerio Simonelli, Antonio Narzisi, Elena Valente, Valentina Viglione, Annarita Milone, Gianluca Sesso
Objectives: The aim of this study was to assess effectiveness and tolerability of Clozapine in the treatment of aggression in youth with Neurodevelopmental Disorders. Methods: Patients were consecutively admitted at our third-level university hospital with nationwide catchment from June 2018 to October 2022, and followed up to July 2023. Eligibility criteria were as follows: (1) Autism Spectrum Disorder (ASD) and/or Intellectual Disability/Borderline Cognitive Functioning, (2) behavioral dyscontrol with physical aggression; (3) age range between 8 and 18 years; (4) clinical indication for Clozapine treatment after at least two failed trials with other Second-Generation Antipsychotics (SGAs); (5) availability of an at least 6-month-long follow-up...
April 2024: Journal of Child and Adolescent Psychopharmacology
https://read.qxmd.com/read/38577753/effectiveness-of-atropine-in-managing-sialorrhea-a-systematic-review-and-meta-analysis
#6
JOURNAL ARTICLE
Venkata K Yellepeddi, Jonathan A Race, Mary M McFarland, Jonathan E Constance, Elika Fanaeian, Nancy A Murphy
OBJECTIVES: To describe the efficacy of atropine in controlling salivary flow in patients with sialorrhea or drooling. MATERIALS AND METHODS: We included randomized controlled studies, quasi-randomized trials, case reports, clinical trials, systematic reviews, and meta-analyses assessing the use of atropine in patients with sialorrhea or drooling. The endpoints were reduction in salivary flow rate, amount of saliva secreted, reduction in clinical symptoms of sialorrhea, death rattle intensity, or reduction in drooling intensity as measured by an objective scale such as the drooling intensity scale...
April 5, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38537033/the-state-of-the-art-in-therapeutic-administration-of-botulinum-toxin-in-children-with-cerebral-palsy-an-integrative-review
#7
JOURNAL ARTICLE
Sandro Rachevsky Dorf, Adriana Rodrigues Fonseca, Flávio Roberto Sztajnbok, Thiffany Rodrigues Delfino de Oliveira, Linamara Rizzo Basttistella
OBJECTIVE: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. DATA SOURCE: An integrative review was conducted. The MEDLINE/PubMed database was searched twice within the last decade using distinct terms, and only studies written in the English language were included. The study population was limited to those aged 0-18 years...
2024: Revista Paulista de Pediatria: Orgão Oficial da Sociedade de Pediatria de São Paulo
https://read.qxmd.com/read/38524401/amyotrophic-lateral-sclerosis-and-pain-a-narrative-review-from-pain-assessment-to-therapy
#8
REVIEW
Vincenzo Pota, Pasquale Sansone, Sara De Sarno, Caterina Aurilio, Francesco Coppolino, Manlio Barbarisi, Francesco Barbato, Marco Fiore, Gianluigi Cosenza, Maria Beatrice Passavanti, Maria Caterina Pace
Amyotrophic lateral sclerosis (ALS) is the most frequent neurodegenerative disease of the motor system that affects upper and lower motor neurons, leading to progressive muscle weakness, spasticity, atrophy, and respiratory failure, with a life expectancy of 2-5 years after symptom onset. In addition to motor symptoms, patients with ALS have a multitude of nonmotor symptoms; in fact, it is currently considered a multisystem disease. The purpose of our narrative review is to evaluate the different types of pain, the correlation between pain and the disease's stages, the pain assessment tools in ALS patients, and the available therapies focusing above all on the benefits of cannabis use...
2024: Behavioural Neurology
https://read.qxmd.com/read/38492517/deep-brain-stimulation-of-the-subthalamic-nucleus-increases-the-risk-of-sialorrhea-in-patients-with-advanced-parkinson-s-disease
#9
JOURNAL ARTICLE
Jinxing Sun, Lian Cheng, Zhenke Li, Junheng Jia, Qianqian Wu, Ying Hou, Qi Wang, Guangjian Zhang, Hong Wang, Xingang Li, Weiguo Li, Chao Zhang
INTRODUCTION: Sialorrhea is a common neurological manifestation of Parkinson's disease (PD). No specifically designed prospective study has tested the effects of deep brain stimulation of the subthalamic nucleus (STN-DBS) on sialorrhea in patients with advanced PD. We focused on the effect of STN-DBS on the incidence of sialorrhea in patients with PD. METHODS: This multicenter, prospective, non-randomized concurrent clinical trial analyzed the incidence of sialorrhea during long-term follow-up in 170 patients with advanced PD (84 patients with STN-DBS and 86 patients with medication therapy)...
March 9, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38470068/european-academy-of-neurology-ean-guideline-on-the-management-of-amyotrophic-lateral-sclerosis-in-collaboration-with-european-reference-network-for-neuromuscular-diseases-ern-euro-nmd
#10
JOURNAL ARTICLE
Philip Van Damme, Ammar Al-Chalabi, Peter M Andersen, Adriano Chiò, Philippe Couratier, Mamede De Carvalho, Orla Hardiman, Magdalena Kuźma-Kozakiewicz, Albert Ludolph, Christopher J McDermott, Jesus S Mora, Susanne Petri, Katrin Probyn, Evy Reviers, François Salachas, Vincenzo Silani, Ole-Bjørn Tysnes, Leonard H van den Berg, Gemma Villanueva, Markus Weber
BACKGROUND: This update of the guideline on the management of amyotrophic lateral sclerosis (ALS) was commissioned by the European Academy of Neurology (EAN) and prepared in collaboration with the European Reference Network for Neuromuscular Diseases (ERN EURO-NMD) and the support of the European Network for the Cure ALS (ENCALS) and the European Organization for Professionals and Patients with ALS (EUpALS). METHODS: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was used to assess the effectiveness of interventions for ALS...
March 12, 2024: European Journal of Neurology
https://read.qxmd.com/read/38465898/gingival-squamous-cell-carcinoma-in-2-lions-under-managed-care
#11
JOURNAL ARTICLE
Hisadora A S C Bom, Telma S Lima, Silvio M C Fonseca, Givaldo B Silva Filho, Nathalia S Wicpolt, Jeann L Araújo, Dênisson S Souza, Márcio A Silva, Brian G Murphy, Javier Asin, Francisco A Uzal, Fábio S Mendonça, Eileen E Henderson
Neoplasia is one of the main causes of euthanasia in geriatric captive nondomestic felids. However, few studies have examined oral tumors in these animals. We describe here the clinicopathologic features of gingival squamous cell carcinoma (SCC) in 2 lions ( Panthera leo ) from separate zoologic collections. In both cases, the lions had a history of sialorrhea, bloody oral discharge, and anorexia. Autopsy findings in both lions were similar and were characterized by poorly circumscribed, friable, and bloody gingival masses with grossly apparent invasion of the mandibular bone; a pathologic fracture was observed in 1 case...
March 11, 2024: Journal of Veterinary Diagnostic Investigation
https://read.qxmd.com/read/38465519/clinical-pharmacokinetics-of-atropine-oral-gel-formulation-in-healthy-volunteers
#12
JOURNAL ARTICLE
Madison Parrot, Bhuvanesh Yathavan, Olga Averin, Logan Hoggard, Joseph E Rower, Michael Voight, Danielle Greene, Ariel Tarrell, Aviva Whelan, Hamidreza Ghandehari, Nancy Murphy, Venkata Yellepeddi
Sialorrhea or drooling is a common problem in children and adults with neurodevelopmental disorders. It can negatively impact the quality of life due to its physical and psychological manifestations. Providers commonly prescribe atropine eye drops for topical administration to the oral mucosa, as an off-label treatment to manage sialorrhea. However, the off-label use of atropine eye drops can be associated with medication and dosing errors and systemic side effects. To address these limitations of treatment, we developed a mucoadhesive topical oral gel formulation of atropine as an alternative route to off-label administration of atropine eye drops...
March 2024: Clinical and Translational Science
https://read.qxmd.com/read/38435899/botulinum-toxin-for-the-management-of-parkinson-s-disease-a-systematic-review
#13
REVIEW
Ethan Slouha, Fadi Ibrahim, Sarah Esposito, Odelin Mursuli, Atbeen Rezazadah, Lucy A Clunes, Theofanis F Kollias
Parkinson's disease (PD) is a terminal, debilitating neurodegenerative disorder typically affecting individuals over 60. It is associated with various conditions that drastically affect the patient's quality of life (QoL). Although there is no cure for PD, its symptoms can be significantly improved and even resolved through different treatments. Mainstay treatments for PD include levodopa combined with carbidopa, dopamine agonists, and even deep brain stimulation (DBS) of the subthalamic nucleus. New treatment methods have emerged, such as botulinum toxin (BoNT), which further improve symptoms and, thus, the QoL of patients with PD...
January 2024: Curēus
https://read.qxmd.com/read/38433339/the-use-of-ipratropium-bromide-for-the-treatment-of-pediatric-sialorrhea-a-retrospective-clinical-case-series
#14
JOURNAL ARTICLE
Suhaima Tunio, Julie E Strychowsky, Agnieszka Dzioba, Peng You, Edward Madou, Breanna A Chen
OBJECTIVE: This retrospective review documents the experience of ipratropium bromide use among pediatric patients with sialorrhea at our multidisciplinary sialorrhea clinic at Children's Hospital at London Health Sciences Centre (LHSC). METHODS: A retrospective chart review of patients diagnosed with sialorrhea at our multidisciplinary clinic between January 2015 and June 2021 was completed. Data on patient demographics, comorbidities, clinical presentation, previous interventions, quality of life, and medication adverse side effects was collected...
March 3, 2024: Annals of Otology, Rhinology, and Laryngology
https://read.qxmd.com/read/38369562/drooling-may-be-associated-with-dysphagia-symptoms-in-multiple-sclerosis
#15
JOURNAL ARTICLE
Merve Sapmaz Atalar, Gençer Genç, Serpil Bulut
During the process of the multiple sclerosis (MS), persons with multiple sclerosis (PwMS) may experience drooling (sialorrhea) issues that are frequently disregarded. The exact cause of drooling in PwMS is poorly understood. This study aims to assess potential risk factors for drooling seen in PwMS. The study included 20 PwMS with drooling and 19 PwMS without drooling. The participants' sociodemographic data and clinical parameters were noted. To evaluate dysphagia, fatigue, and hypersalivation, the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS), the Fatigue Severity Scale (FSS), and objective saliva flow rate measurement with cottons placed in Stensen ducts and under the tongue (swab test) were used, respectively...
February 19, 2024: Dysphagia
https://read.qxmd.com/read/38332959/pharmacologic-management-of-sialorrhea-in-neonatal-and-pediatric-patients
#16
JOURNAL ARTICLE
Caitlyn V Bradford, Avery M Parman, Peter N Johnson, Jamie L Miller
Sialorrhea, defined as an excess flow of saliva or excessive secretions, is common in patients with cerebral palsy and other neurologic disorders and is associated with clinical complications such as increased risk of local skin reactions, infections, aspiration, pneumonia, and dehydration. Upon failure of non-pharmacologic measures, clinicians have several noninvasive pharmacologic options available to manage sialorrhea. This review of the literature provides detailed descriptions of medications used, efficacy, safety, and practical considerations for use of non-injectable pharmacologic agents...
2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38307188/botulinum-toxin-type-a-blocks-aquaporin-5-trafficking-by-decreasing-synaptosomal-associated-protein-23-in-submandibular-acinar-cells
#17
JOURNAL ARTICLE
Hui Xu, Huabing Ge, Zhigang Cai
The trafficking of aquaporin 5 (AQP5) is critical for salivary secretion. Synaptosomal-associated protein 23 (SNAP23) is an important regulator in the process of membrane fusion. However, the role of SNAP23 on AQP5 trafficking has not been explored. Botulinum toxin type A (BoNT/A) is a bacterial toxin that effectively treats sialorrhea. We previously reported that BoNT/A induced AQP5 redistribution in cultured acinar cells, but the mechanism remained unclear. In this study, SNAP23 was predominantly localized to the plasma membrane of acinar cells in the rat submandibular gland (SMG) and colocalized with AQP5 at the apical membrane of acinar cells...
January 31, 2024: Experimental Cell Research
https://read.qxmd.com/read/38294288/onabotulinum-toxin-a-bont-a-for-drooling-in-children-a-systematic-review-and-meta-analysis
#18
REVIEW
Haresh Oad, Alix Maltezeanu, Sabrina D da Silva, Sam J Daniel
INTRODUCTION: Sialorrhea, also known as drooling, hypersalivation, or ptyalism, has a significant impact on the medical and psychosocial well-being of children. Onabotulinum toxin A (BoNT-A) is the most commonly used botulinum toxin worldwide for the treatment of sialorrhea in children. OBJECTIVES: To conduct a comprehensive systematic review and meta-analysis to assess the clinical efficacy and potential adverse effects of BoNT-A as a treatment for drooling in children...
January 31, 2024: Laryngoscope
https://read.qxmd.com/read/38294269/the-usefulness-of-salivary-gland-organoids-for-evaluation-of-the-potency-of-botulinum-neurotoxin
#19
JOURNAL ARTICLE
Yeo-Jun Yoon, Jae-Yol Lim
BACKGROUND AND OBJECTIVES: Botulinum neurotoxin (BoNT) is a substance used to treat chronic sialorrhea, muscle dystonia, and is used in cosmetic applications. Measuring the potency of BoNT is crucial because it acts even with a small amount. However, the current methods for measuring the potency of BoNT involve using two-dimensional neuroblastoma cell line-based methods. In this study, we aimed to develop a new method to measure the potency of BoNT using a three-dimensional organoid culture system...
January 31, 2024: Laryngoscope
https://read.qxmd.com/read/38264389/a-palliative-care-approach-to-amyotrophic-lateral-sclerosis
#20
JOURNAL ARTICLE
Cláudio Gouveia, Licínia Araújo, Susete Freitas, João Correia, Vilma Passos, Graciela Camacho, Luísa Gomes, Helena Fragoeiro, Cristiana Camacho, Beatriz Chambino
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a degenerative disease characterized by motor dysfunction. Currently, treatment options are limited and management is based mostly on symptom control and quality of life optimization, so palliative care plays a fundamental role. Our objective was to characterize the ALS population in Madeira Island that was referenced and/or followed by a palliative care unit over a five-year period. METHODS: Longitudinal, retrospective, descriptive, and observational study to analyze patients with ALS who were referred and/or followed by a palliative care unit during a five-year period, between 2017 and 2021...
December 2023: Curēus
keyword
keyword
6609
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.